,293,mitoparp,293 + low NAD,mitoparp + low NAD,subsystem
1PPDCRc_MitoCore,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
1PPDCRc_NADPH_MitoCore,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
2HBO,-0.012,0.0,0.0,0.0,Threonine and Methionine degradation
2HBt2,-0.012,0.0,0.0,0.0,Boundary Conditions - Biomarkers
2OXOADOXm,0.03,0.03,0.008603773584905659,0.008603773584905659,Tryptophan / Lysine Metabolism 
34HPPOR,0.0,0.0,0.022858823529411765,0.022858823529411765,Tyrosine degradation
3HBCOAHLm,0.011000000000001012,0.011,0.002416184971098266,0.002416184971098266,Valine degradation
3SALATAi,0.0,0.0,0.0,0.0,Cysteine degradation I
3SPYRSP,0.0,0.0,0.0,0.0,Cysteine degradation I
4ABUTtm,0.0,0.0,0.8481533125361351,0.0,GABA shunt - transport
4aabutn_MitoCore,0.0,0.0,0.0,0.0,Arginine degradation
5AOPtm,0.0,0.0,0.0,0.0,Haem Synthesis
AACTOORm_MitoCore,0.0,0.0,0.0,0.0,Glycine degradation
AASAD3m,0.0,0.0,0.0043018867924528295,0.0043018867924528295,Lysine degradation (saccharopine pathway)
ABTArm,0.0,0.0,0.8481533125361351,0.0,GABA shunt
ABUTD,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
ACACT10m,0.004,0.004,0.002161702127659575,0.002161702127659575,Isoleucine degradation
ACACT1rm,-0.682304347826087,-0.6776739130434728,-0.5604710494605712,-0.5007729898107098,FA and ketone body metabolism / Ketogenesis
ACACt2,0.114,0.114,0.114,0.03343952224412266,Boundary conditions - core
ACACt2mB_MitoCore,0.114,0.114,0.13685882352941175,0.056298345773534424,Mitochondrial transporters - characterised
ACADLC14_MitoCore,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.4044240619416316,FA metabolism
ACADLC16_MitoCore,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.4044240619416316,FA metabolism
ACALDtm,0.0,0.0,0.0,0.0,Alcohol metabolism
ACCOAC,0.0,0.0,0.0,0.07548076923079818,FA synthesis - cytosolic
ACCOALm,0.0,0.0,0.0,0.0,Propanoate metabolism
ACITL,0.0,0.0,0.0,0.09626373626376934,Reductive carboxylation / Acetyl-CoA production for biosynthesis
ACITLm_MitoCore,0.0,0.0,0.0,0.0,TCA cycle periphery
ACOAHi,0.0,0.0,0.0,0.01,Acetate production
ACOATA,0.0,0.0,0.0,0.010782967032971168,FA synthesis - cytosolic
ACONT,-0.09600000000016164,0.0,-0.09626373626373627,-0.09626373626376934,Reductive carboxylation
ACONTm,6.907434782608816,6.825391304347811,4.950973570539001,4.877781840632908,TCA cycle
ACOT2_MitoCore,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
ACSm,0.0,0.0,0.0,0.0,Alcohol metabolism
ACt2r,0.0,0.0,0.0,-0.01,Boundary Conditions - Biomarkers
ADK1,0.47430434782608694,0.4696739130434737,0.38356164383561797,0.40442406194163166,Cytosolic misc
ADK1m,0.0,0.0,0.006,0.006,TCA cycle periphery
ADNK1,0.0,0.0,0.0,0.0,Methionine degradation
ADSL1,0.0,0.0,0.0,0.0,Purine Nucleotide Cycle
ADSS,0.0,0.0,0.0,0.0,Purine Nucleotide Cycle
AGMTm,0.0,0.0,0.0,0.0,Arginine degradation
AHC,0.0,0.0,0.0,0.0,Methionine degradation
AKGDm,6.8324347826086544,6.846391304347811,4.02755652173913,3.9600268270120256,TCA cycle
AKGMALtm,2.4880000000001616,2.4040000000000243,3.7386592571392323,2.958766217307398,Malate aspartate shuttle
AKGt_MitoCore,0.0,0.0,0.0,-0.8424912773571469,Boundary Conditions - Biomarkers
ALASm,0.0,0.0,0.0,0.0,Haem Synthesis
ALATA_L,0.009000000000000001,0.009000000000000001,0.7061569838867712,0.009000000000000001,Cytosolic misc
ALAt2r,0.01,0.01,0.01,0.01,Boundary conditions - nonessential amino acids
ALCD2if,0.0,0.0,0.0,0.0,Alcohol metabolism
ALCD2yf,0.0,0.0,0.0,0.0,Alcohol metabolism
ALDD2x,0.0,0.0,0.0,0.0,Alcohol metabolism
ALDD2xm,0.0,0.0,0.0,0.0,Alcohol metabolism
AMCOXO,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
AMCOXO2_MitoCore,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
AMPD1,0.0,0.0,0.0,0.0,Purine Nucleotide Cycle
AMPTASECG,0.0,0.0,0.0,0.0,Glutathione degradation
AOBUTDsm,0.0,0.0,0.0,0.0,Glycine degradation
APAT2rm,0.0,0.0,0.0,0.0,Beta-alanine degradation
APRTO2m_MitoCore,0.0,0.0,0.0,0.0,Arginine degradation
ARGDCm,0.0,0.0,0.0,0.0,Arginine degradation
ARGN,0.007,0.007,0.0,0.0,Urea Cycle
ARGNm,0.0,0.0,0.007,0.007,Urea Cycle
ARGSL,0.0,0.0,0.0,0.0,Urea Cycle
ARGSS,0.0,0.0,0.0,0.0,Urea Cycle
ARGSUCt_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
ARGtiDF,0.007,0.007,0.007,0.007,Boundary conditions - nonessential amino acids
ARGtmB_MitoCore,0.0,0.0,0.007,0.007,Mitochondrial transporters - characterised
ASNS1,0.0,0.0,0.0,0.0,Asparagine synthesis
ASNtm,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
ASP1DC,0.0,0.0,0.0,0.0,Beta-alanine synthesis
ASPGLUmB_MitoCore,2.219,2.2310000000000243,2.8042422083393608,1.8800148750371535,Malate aspartate shuttle
ASPTA,2.383,2.3950000000000244,2.9682422083393623,2.0440148750371536,Malate aspartate shuttle
ASPTAm,-2.219,-2.2310000000000243,-2.8042422083393608,-1.8800148750371535,Malate aspartate shuttle
ASPte,-0.154,-0.154,-0.154,-0.154,Boundary conditions - nonessential amino acids
ATPtmB_MitoCore,99.91685713769179,100.01153264972396,70.57576953715204,65.79573094457537,Mitochondrial transporters - characterised
BALAtmr,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
BDHm,0.048,0.048,0.016800000000000002,0.016800000000000002,Ketone bodies - degradation
BHBt,0.048,0.048,0.016800000000000002,0.016800000000000002,Boundary conditions - core
BHBtmB_MitoCore,0.048,0.048,0.016800000000000002,0.016800000000000002,Mitochondrial transporters - uncharacterised
BILIRED,0.0,0.0,0.0,0.0,Haem Degradation
BILIRED2_MitoCore,0.0,0.0,0.0,0.0,Haem Degradation
BUTt2mB_MitoCore,0.0,0.0,0.006,0.006,Mitochondrial transporters - uncharacterised
BUTt2r,0.0,0.0,0.006,0.006,Boundary conditions - alternative fuels
Biomass_MitoCore,-100.87424844203977,-100.882184823637,-71.56378433296975,-66.49206883862146,Boundary conditions - core
Biomasst_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transport - diffusion / artificial
C160CPT1,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.4044240619416316,Carnitine shuttle
C160CPT2,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.4044240619416316,Carnitine shuttle
CBPSam,0.0,0.0,0.0,0.0,Citrulline biosynthesis
CDSm,0.0,0.0,0.0,0.0,Cardiolipin synthesis
CHLtmB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
CHOLtu,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
CIII_MitoCore,39.541293836598186,39.541310906484824,28.83778227675532,26.39555568978551,Electron transport chain
CII_MitoCore,6.832434782608655,6.873391304347836,4.8757098342752645,3.973791948153333,Electron transport chain
CITtamB,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
CITtbm,-0.09600000000016164,0.0,-0.09626373626373627,0.0,Mitochondrial transporters - characterised
CIV_MitoCore,19.770646918299093,19.770655453242412,14.41889113837766,13.197777844892755,Electron transport chain
CI_MitoCore,29.35308170090784,29.344546757590265,21.266297073369035,19.578263412117728,Electron transport chain
CK,0.0,0.0,0.0,0.0,Creatine ATP buffer
CKc,0.0,0.0,0.0,0.0,Creatine ATP buffer
CLPN_MitoCore,0.0,0.0,0.0,0.0,Cardiolipin synthesis
CLS_hsm_MitoCore,0.0,0.0,0.0,0.0,Cardiolipin synthesis
CO2t,-16.59086956521739,-16.63678260869569,-12.178192149229094,-10.513222120701665,Boundary conditions - core
CO2tm,-16.63386956521747,-16.63178260869569,-11.350311881295415,-10.382533626842525,Mitochondrial transport - diffusion / artificial
COAtmB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
COAtmC_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
COt,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
CPPPGO,0.0,0.0,0.0,0.0,Haem Synthesis
CREATtmdiffir,0.0,0.0,0.0,0.0,Mitochondrial transport - diffusion / artificial
CSm,6.8114347826086545,6.825391304347811,4.854709834275265,4.877781840632908,TCA cycle
CV_MitoCore,93.3744223550833,93.35914134537614,68.32962479719265,62.558963413044545,Electron transport chain
CYANt,0.0,0.0,0.001,0.0,Boundary Conditions - Misc
CYANtm,0.0,0.0,0.0,0.0,Mitochondrial transport - diffusion / artificial
CYSTA,0.0,0.0,0.001,0.0,Cysteine degradation II
CYSTAm,0.001,0.001,0.0,0.001,Cysteine degradation II
CYSTGL,0.0,0.0,0.0,0.0,Methionine and Serine degradation
CYSTS,0.0,0.0,0.0,0.0,Methionine and Serine degradation
CYStec,0.001,0.001,0.001,0.001,Boundary conditions - nonessential amino acids
CYTK1m,0.0,0.0,0.0,0.0,Cardiolipin synthesis
DHFR,0.0,0.0,0.0,0.0,Folate cytosolic
DHPR,0.0,0.0,0.011858823529411765,0.011858823529411765,Phenylalanine degradation
ECOAH12m,0.011,0.011,0.002416184971098266,0.002416184971098266,Valine degradation
ECOAH1m,-0.5043043478260869,-0.49967391304347375,-0.398165417420522,-0.4190278355265367,FA metabolism
ECOAH9m,0.004,0.004,0.002161702127659575,0.002161702127659575,Isoleucine degradation
ENO,1.81,1.81,1.6588743472252139,1.6769305234239302,Glycolysis/gluconeogenesis
ETOHt,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
FA160ACPH,0.0,0.0,0.0,0.010782967032971167,FA synthesis - cytosolic
FACOAL160i,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.40442406194163166,Carnitine shuttle
FACOAL40im,0.0,0.0,0.006,0.006,Butanoate metabolism
FBA,0.9,0.9,0.8523684210526316,0.8523684210526317,Glycolysis/gluconeogenesis
FBP,0.0,0.0,0.0,0.0,Gluconeogenesis
FCLTm,0.0,0.0,0.0,0.0,Haem Synthesis
FE2t,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
FE2tm,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
FKYNH,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
FOLR2,0.0,0.0,0.0,0.0,Folate cytosolic
FOLt_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
FORt2mB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
FORt_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
FTCD,0.010000000000000002,0.01,0.01,0.01,Folate cytosolic
FTHFDH,0.053000000000080816,0.005,0.05313186813186814,0.12861263736266632,Folate cytosolic
FTHFDHm_MitoCore,0.0,0.0,0.0,0.0,Folate mitochondrial
FTHFL,0.0,0.0,0.0,0.0,Folate cytosolic
FTHFLm,0.0,0.0,0.0,0.0,Folate mitochondrial
FUM,0.0,0.0,0.022858823529411765,0.022858823529411765,Cytosolic misc
FUMAC,0.0,0.0,0.022858823529411765,0.022858823529411765,Tyrosine degradation
FUMm,6.832434782608655,6.873391304347836,4.8757098342752645,3.973791948153333,TCA cycle
FUMt_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
FUMtmB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
G3PD1,0.01,0.01,0.009718309859229715,0.009718309859154929,Glycerol phosphate shuttle
G5SADrm,-0.004,-0.004,-0.004,-0.004,Proline degradation/synthesis
G5SDym,0.0,0.0,0.0,0.0,Proline synthesis
G6PDH2r,0.0,0.0,0.0,0.0,Pentose phosphate pathway
G6PPer,0.0,0.0,0.0,0.0,Gluconeogenesis
GAPD,1.81,1.81,1.7147368421052631,1.7147368421052633,Glycolysis/gluconeogenesis
GCCam,0.026000000000040407,0.0019999999999999996,0.02606593406593407,0.06380631868133316,Glycine cleavage system (GCS)
GCCbim,0.026000000000040407,0.0019999999999999996,0.02606593406593407,0.06380631868133316,Glycine cleavage system (GCS)
GCCcm,0.026000000000040407,0.0019999999999999996,0.02606593406593407,0.06380631868133316,Glycine cleavage system (GCS)
GHMT2r,0.043000000000080814,-0.005,0.04313186813186814,0.11861263736266632,Serine and glycine biosynthesis
GHMT2rm,-0.026000000000040407,-0.0019999999999999996,-0.02606593406593407,-0.06380631868133316,Serine and glycine biosynthesis
GLCt1r,0.9,0.9,0.8523684210526316,0.8523684210526317,Boundary conditions - core
GLNS,0.0,0.0,0.0,0.0,Glutamine synthesis
GLNtm,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
GLU5Km,0.0,0.0,0.0,0.0,Proline synthesis
GLUCYS,0.0,0.0,0.0,0.0,Glutathione synthesis
GLUDC,0.0,0.0,0.8481533125361351,0.0,GABA shunt
GLUDxi,0.0,0.0,0.0,0.018056176198717466,Glutamate degradation/synthesis - cytosolic
GLUDxm,0.26464691829909265,0.29400000000000004,0.1002142857142857,0.10021428571428428,Glutamate degradation/synthesis
GLUDy,0.0,0.0,0.0,0.0,Glutamate degradation/synthesis - cytosolic
GLUDym,0.029353081700907842,0.0,0.1002142857142857,0.10021428571428428,Glutamate degradation/synthesis
GLUN_MitoCore,0.0,0.0,0.0,0.0,Glutamine degradation - cytosolic
GLUNm,0.0,0.0,0.0,0.0,Glutamine degradation
GLUt2mB_MitoCore,0.18300000000000027,0.18300000000000005,0.0,0.1499963286493611,Mitochondrial transporters - characterised
GLUt_MitoCore,0.0,0.0,0.0,0.0,Boundary conditions - nonessential amino acids
GLYC3Ptm,0.0,0.0,0.0,0.0,Cardiolipin synthesis
GLYCt,-0.01,-0.01,-0.01,-0.01,Boundary conditions - alternative fuels
GLYCtm,0.0,0.0,0.0,0.0,Mitochondrial transport - diffusion / artificial
GLYK,0.01,0.01,0.01,0.01,Cardiolipin synthesis
GLYOXm,0.0,0.0,0.0,0.0,Glycine degradation
GLYt2r,0.009,0.009,0.009,0.009,Boundary conditions - nonessential amino acids
GLYtm,0.052000000000080815,0.003999999999999999,0.05213186813186814,0.12761263736266631,Mitochondrial transporters - uncharacterised
GND,0.0,0.0,0.0,0.0,Pentose phosphate pathway
GPAMm_hsB_MitoCore,0.0,0.0,0.0,0.0,Cardiolipin synthesis
GTHO,0.0,0.0,0.0,0.0,ROS defense
GTHOm,0.029353081700907842,0.029344546757590267,0.021266297073369037,0.019578263412117727,ROS defense
GTHP,0.0,0.0,0.0,0.0,ROS defense
GTHPm,0.029353081700907842,0.029344546757590267,0.021266297073369037,0.019578263412117727,ROS defense
GTHS,0.0,0.0,0.0,0.0,Glutathione synthesis
GluForTx,0.01,0.01,0.01,0.01,Histidine degradation
H2Ot,-14.971260869565176,-15.026434782608723,-12.400879021979847,-10.74800343481965,Boundary Conditions - Misc
H2Otm,-114.60981365943114,-114.6202935192892,-82.87220383810137,-76.17120196553317,Mitochondrial transport - diffusion / artificial
HACD1m,-0.5043043478260869,-0.49967391304347375,-0.398165417420522,-0.4190278355265367,FA metabolism
HACD9m,0.004,0.004,0.002161702127659575,0.002161702127659575,Isoleucine degradation
HCO3t_MitoCore,0.016,0.04300000000002348,1.5108424134759562,0.7187600315691374,Boundary conditions - core
HDCAtm_MitoCore,0.0,0.0,0.0,0.0,Boundary conditions - core
HDCAtr,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.3936410949086605,Boundary conditions - core
HEX1,0.9,0.9,0.8523684210526316,0.8523684210526317,Glycolysis
HGNTOR,0.0,0.0,0.022858823529411765,0.022858823529411765,Tyrosine degradation
HIBDm,0.011000000000001012,0.011,0.002416184971098266,0.002416184971098266,Valine degradation
HISD,0.01,0.01,0.01,0.01,Histidine degradation
HIStiDF,0.01,0.01,0.01,0.01,Boundary conditions - essential amino acids
HKYNH,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
HMBS,0.0,0.0,0.0,0.0,Haem Synthesis
HMGCOASim,0.0,0.0,0.0,0.0,Ketogenesis
HMGLm,0.016,0.015999999999999043,0.008646808510637483,0.0086468085106383,Ketogenesis / Leucine degradation
HOXG,0.0,0.0,0.0,0.0,Haem Degradation
Hct_MitoCore,2.5613043478261557,2.496673913043516,2.988103974912534,1.2929651097965649,Boundary Conditions - Misc
Hmt_MitoCore,-1.9322938365982925,-1.8303109064847944,-2.6064634122572126,-1.7207767518266364,Boundary Conditions - Misc
HtmB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
ICDHxm,6.907434782608816,6.79604675759022,5.496728501326222,4.954115976142622,TCA cycle
ICDHy,-0.09600000000016164,0.0,-0.09626373626373627,-0.09626373626373627,Reductive carboxylation
ICDHyrm,0.0,0.029344546757590267,-0.5457549307872207,-0.07633413550971373,TCA cycle
ICITt_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
ILETAm,0.004,0.004,0.002161702127659575,0.002161702127659575,Isoleucine degradation
ILEt5m,0.004,0.004,0.002161702127659575,0.002161702127659575,Mitochondrial transporters - uncharacterised
ILEtec,0.004,0.004,0.002161702127659575,0.002161702127659575,Boundary conditions - essential amino acids
IZPN,0.01,0.01,0.01,0.01,Histidine degradation
KYN3OX,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
LDH_Dm_MitoCore,0.0,0.0,0.0,0.0,Glycine degradation
LDH_L,0.575,0.575,0.3718197879858657,0.3718197879858657,Glycolysis/gluconeogenesis
LEUTAm,0.016,0.016,0.0086468085106383,0.0086468085106383,Leucine degradation
LEUt5m,0.016,0.016,0.0086468085106383,0.0086468085106383,Mitochondrial transporters - uncharacterised
LEUtec,0.016,0.016,0.0086468085106383,0.0086468085106383,Boundary conditions - essential amino acids
LGTHLm_MitoCore,0.0,0.0,0.0,0.0,Glycine degradation
LPCOXc_MitoCore,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
LYSOXc_MitoCore,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
LYStiDF,0.03,0.03,0.008603773584905659,0.008603773584905659,Boundary conditions - essential amino acids
LYStmB_MitoCore,0.03,0.03,0.008603773584905659,0.008603773584905659,Mitochondrial transporters - characterised
L_LACt2r,0.575,0.575,0.3718197879858657,0.3718197879858657,Boundary conditions - core
MACACI,0.0,0.0,0.022858823529411765,0.022858823529411765,Tyrosine degradation
MALSO3tm,0.0,0.0,0.0,-0.001,Mitochondrial transporters - characterised
MALSO4tm,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
MALTSULtm,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
MAL_Lte,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
MALtm,-0.10500000000016163,-0.009000000000000001,-1.575521822308825,-0.7946287824770635,Mitochondrial transporters - characterised
MCCCrm,0.016,0.015999999999999043,0.0086468085106383,0.0086468085106383,Leucine degradation
MCLOR,0.0,0.0,0.0,0.0,Cysteine degradation II
MCOATA,0.0,0.0,0.0,0.07548076923079818,FA synthesis - cytosolic
MCPST,0.0,0.0,0.001,0.0,Cysteine degradation II
MCPSTm_MitoCore,0.0,0.0,0.0,0.0,Cysteine degradation II
MDH,-2.383,-2.3950000000000244,-2.140278611300996,-2.1402786113009227,Malate aspartate shuttle
MDHm,9.126434782608817,9.056391304347835,6.253020173913044,6.136929382983668,TCA cycle
ME1m,0.08899999999983876,0.21200000000002506,0.31471826625387017,0.0,TCA cycle periphery
ME2,0.0,0.0,0.0,0.0,Cytosolic misc
ME2m,0.0,0.0,0.4711088289387555,0.0,TCA cycle periphery
MECR14C_MitoCore,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
MECR16C_MitoCore,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
MERCPLACt_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
METAT,0.0,0.0,0.0,0.0,Methionine degradation
METAT2_MitoCore,0.0,0.0,0.0,0.0,Methionine degradation
METtec,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
MGCHrm,0.016,0.015999999999999043,0.0086468085106383,0.0086468085106383,Leucine degradation
MMCDm,0.0,0.0,0.0,0.0,Propanoate synthesis
MMEm,0.0,-0.027000000000024435,0.0,-0.013765121141307315,Propanoate metabolism
MMMm,0.0,0.027000000000024435,0.0,0.013765121141307315,Propanoate metabolism
MMSAD1m,0.011000000000001012,0.011,0.002416184971098266,0.002416184971098266,Propanoate metabolism
MMSAD3m,0.0,0.0,0.0,0.0,Beta-alanine degradation
MMSAD3m2_MitoCore,0.0,0.0,0.0,0.0,Beta-alanine degradation
MTHFC,0.053000000000080816,0.005,0.05313186813186814,0.12861263736266632,Folate cytosolic
MTHFCm,0.0,0.0,0.0,0.0,Folate mitochondrial
MTHFD,0.043000000000080814,-0.005,0.04313186813186814,0.11861263736266632,Folate cytosolic
MTHFD2m,0.0,0.0,0.0,0.0,Folate mitochondrial
MTHFDm,0.0,0.0,0.0,0.0,Folate mitochondrial
MTPC14_MitoCore,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.4044240619416316,FA metabolism
MTPC16_MitoCore,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.4044240619416316,FA metabolism
NABTNOm,0.0,0.0,0.0,0.0,Arginine degradation
NADHt_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NADHtm_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NADt_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NADtm_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NDPK1,0.0,0.0,0.0,0.0,Cytosolic misc
NDPK1m,0.0,0.0,0.0,0.0,TCA cycle periphery
NDPK3m,0.0,0.0,0.0,0.0,Cardiolipin synthesis
NH4t3r,0.36200000000004096,0.36200000000000004,0.26568173953705865,0.3214783003511687,Boundary Conditions - Biomarkers
NNT_MitoCore,0.0,0.0,0.0,0.0,TCA cycle periphery
NOS1,0.0,0.0,0.0,0.0,NOS Signalling
NOS2,0.0,0.0,0.0,0.0,NOS Signalling
NOt,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
O2t,19.8,19.8,14.497733906039265,13.27493257889311,Boundary conditions - core
O2tm,19.8,19.8,14.44015743545103,13.217356108304873,Mitochondrial transport - diffusion / artificial
OAAt_MitoCore,0.0,0.0,-0.8279635970383663,0.0,Boundary Conditions - Biomarkers
OCBTm,0.0,0.0,0.0,0.0,Citrulline biosynthesis
OCOAT1m,0.178,0.17799999999999905,0.16230563204004925,0.08174515428417273,Ketone bodies - degradation
OF_ATP_MitoCore,100.87424844203977,100.882184823637,71.56378433296975,66.49206883862146,Objective Function - ATP 
OF_HEME_MitoCore,0.0,0.0,0.0,0.0,Objective Function - Heme
OF_LIPID_MitoCore,0.0,0.0,0.0,0.0,Objective Function - Lipid synthesis 
OF_PROTEIN_MitoCore,0.0,0.0,0.0,0.0,Objective Function - Protein Synthesis
OIVD1m,0.016,0.016,0.0086468085106383,0.0086468085106383,Leucine degradation
OIVD2m,0.011,0.011,0.002416184971098266,0.002416184971098266,Valine degradation
OIVD3m,0.004,0.004,0.002161702127659575,0.002161702127659575,Isoleucine degradation
ORNDC,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
ORNTArm,0.007,0.007,0.007,0.007,Ornithine degradation
ORNt3mB_MitoCore,-0.007,-0.007,0.0,0.0,Mitochondrial transporters - characterised
ORNt4mB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
P5CRm,0.0,0.0,0.0,0.0,Proline synthesis
P5CRxm,0.0,0.0,0.0,0.0,Proline synthesis
PCFLOPm,0.0,0.0,0.0,0.0,Mitochondrial transport - lipids
PCHOLHSTDe,0.0,0.0,0.0,0.0,Boundary Conditions - Lipids
PCHOLPm_hs,0.0,0.0,0.0,0.0,Cardiolipin synthesis
PCLAD,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
PCREATtmdiffirB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transport - diffusion / artificial
PCm,0.0,0.0,1.5021956049653178,0.6208673326863936,TCA cycle periphery
PDHm,2.58099999999996,2.6320000000000245,1.4215893617021276,1.4388829787234019,TCA cycle
PEFLIPm,0.0,0.0,0.0,0.0,Mitochondrial transport - lipids
PEPCK,0.0,0.0,0.0,0.0,Gluconeogenesis
PEPCKm,0.09600000000016164,0.0,0.09626373626373627,0.0,TCA cycle periphery
PEt,0.0,0.0,0.0,0.0,Boundary Conditions - Lipids
PFK,0.9,0.9,0.8523684210526316,0.8523684210526317,Glycolysis
PGCD,0.0,0.0,0.05586249488004924,0.037806318681333155,Serine and glycine biosynthesis
PGI,0.9,0.9,0.8523684210526316,0.8523684210526317,Glycolysis/gluconeogenesis
PGK,-1.81,-1.81,-1.7147368421052631,-1.7147368421052633,Glycolysis/gluconeogenesis
PGL,0.0,0.0,0.0,0.0,Pentose phosphate pathway
PGM,-1.81,-1.81,-1.6588743472252139,-1.6769305234239302,Glycolysis/gluconeogenesis
PGPPTm,0.0,0.0,0.0,0.0,Cardiolipin synthesis
PGPP_hsm_MitoCore,0.0,0.0,0.0,0.0,Cardiolipin synthesis
PHEMEtm,0.0,0.0,0.0,0.0,Haem Synthesis
PHEtec,0.0,0.0,0.011858823529411765,0.011858823529411765,Boundary conditions - essential amino acids
PIt2mB_MitoCore,99.90785713769179,100.00253264972395,69.09651145110695,65.0001021620983,Mitochondrial transporters - characterised
PPA,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.40442406194163166,Carnitine shuttle
PPAm,0.0,0.0,0.006,0.006,Carnitine shuttle
PPAt,-0.015000000000001013,0.0,-0.013765121141311034,0.0,Boundary Conditions - Biomarkers
PPAtmB_MitoCore,-0.015000000000001013,0.0,-0.013765121141311034,0.0,Mitochondrial transporters - uncharacterised
PPCOACm,0.0,0.027000000000024435,0.0,0.013765121141307315,Propanoate metabolism
PPD2CSPc_MitoCore,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
PPPGOmB_MitoCore,0.0,0.0,0.0,0.0,Haem Synthesis
PROD2mB_MitoCore,0.004,0.004,0.004,0.004,Proline degradation
PROt2r,0.004,0.004,0.004,0.004,Boundary conditions - nonessential amino acids
PROtm,0.004,0.004,0.004,0.004,Mitochondrial transporters - uncharacterised
PSERT,0.0,0.0,0.05586249488004924,0.037806318681333155,Serine and glycine biosynthesis
PSFLIPm,0.0,0.0,0.0,0.0,Mitochondrial transport - lipids
PSP_L,0.0,0.0,0.05586249488004924,0.037806318681333155,Serine and glycine biosynthesis
PSt3,0.0,0.0,0.0,0.0,Boundary Conditions - Lipids
PTRCAT1m_MitoCore,0.0,0.0,0.0,0.0,Arginine degradation
PTRCOX1,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
PYK,1.9060000000001618,1.81,1.75513808348895,1.6769305234239302,Glycolysis/gluconeogenesis
PYRt2m,2.4900000000001214,2.4179999999999997,2.834114855361587,2.0577503114097957,Mitochondrial transporters - characterised
R03103_MitoCore,0.03,0.03,0.0043018867924528295,0.0043018867924528295,Lysine degradation (saccharopine pathway)
RE1254C,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
RE2649M,0.015000000000001013,0.0,0.013765121141311034,0.0,Propanoate synthesis
RPE,0.0,0.0,0.0,0.0,Pentose phosphate pathway
RPI,0.0,0.0,0.0,0.0,Pentose phosphate pathway
SACCD3m,0.03,0.03,0.008603773584905659,0.008603773584905659,Lysine degradation (saccharopine pathway)
SO3t_MitoCore,0.001,0.001,0.0,0.001,Boundary Conditions - Misc
SPODMm,0.029353081700907842,0.029344546757590267,0.021266297073369037,0.019578263412117727,ROS defense
SUCCt2m,0.0,0.0,0.0,-0.001,Mitochondrial transporters - characterised
SUCCt3m_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
SUCOAS1m,-0.09600000000016164,0.0,-0.09626373626373627,0.0,TCA cycle
SUCOASm,-6.558434782608494,-6.695391304347837,-3.7689871534353445,-3.8920467938691603,TCA cycle
SUMt_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
TALA,0.0,0.0,0.0,0.0,Pentose phosphate pathway
TCYNTt,0.0,0.0,0.001,0.0,Boundary Conditions - Misc
TCYNTtmB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transport - diffusion / artificial
THRD_L,0.012,0.012,0.009187234042553193,0.009187234042549473,Threonine degradation
TKT1,0.0,0.0,0.0,0.0,Pentose phosphate pathway
TKT2,0.0,0.0,0.0,0.0,Pentose phosphate pathway
TPI,0.91,0.91,0.8623684210526316,0.8623684210526317,Glycolysis/gluconeogenesis
TRPO2,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
TRPt,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
TRPtm_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
TSULt_MitoCore,-0.001,-0.001,0.0,-0.001,Boundary Conditions - Misc
TYRTA,0.0,0.0,0.022858823529411765,0.022858823529411765,Tyrosine degradation
TYRTB_MitoCore,0.0,0.0,0.0,0.0,Tyrosine degradation
TYRt,0.0,0.0,0.011,0.011,Boundary conditions - nonessential amino acids
UPPDC1,0.0,0.0,0.0,0.0,Haem Synthesis
URCN,0.01,0.01,0.01,0.01,Histidine degradation
UREAt,-0.007,-0.007,-0.007,-0.007,Boundary Conditions - Biomarkers
UREAtm,0.0,0.0,-0.007,-0.007,Mitochondrial transporters - uncharacterised
VALTAm,0.011,0.011,0.002416184971098266,0.002416184971098266,Valine degradation
VALt5m,0.011,0.011,0.002416184971098266,0.002416184971098266,Mitochondrial transporters - uncharacterised
VALtec,0.011,0.011,0.002416184971098266,0.002416184971098266,Boundary conditions - essential amino acids
r0060,0.0,0.024,0.0,0.0,Serine degradation
r0074,0.011,0.011,0.011,0.011,Proline / ornithine degradation
r0081,0.001,0.001,-0.6961569838867712,0.001,TCA cycle periphery
r0122,0.0,0.0,0.0,0.0,Glycolysis
r0127,0.01,0.01,0.01,0.01,Asparagine degradation
r0129,0.0,0.0,0.0,0.0,Glutathione degradation
r0178,0.0,0.0,0.8481533125361351,0.0,GABA shunt
r0193,0.0,0.0,0.0,0.0,Cysteine degradation III
r0205,0.0,0.0,0.0002816901407702854,0.0002816901408450711,Glycerol phosphate shuttle
r0226,0.0,0.0,0.0,0.0,Folate mitochondrial
r0287,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.40442406194163105,FA metabolism
r0399,0.0,0.0,0.011858823529411765,0.011858823529411765,Phenylalanine degradation
r0450,0.03,0.03,0.008603773584905659,0.008603773584905659,Lysine degradation (saccharopine pathway)
r0464c_MitoCore,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
r0514,0.0,0.0,0.0,0.0,Folate mitochondrial
r0525,0.03,0.03,0.008603773584905659,0.008603773584905659,Lysine degradation (saccharopine pathway)
r0541,0.03,0.03,0.008603773584905659,0.008603773584905659,Tryptophan / Lysine Metabolism 
r0560,0.011,0.011,0.002416184971098266,0.002416184971098266,Valine degradation
r0594,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
r0595B_MitoCore,0.0,0.0,0.0,0.0,Cysteine degradation II
r0595m_MitoCore,0.001,0.001,0.0,0.001,Cysteine degradation II
r0603,0.004,0.004,0.002161702127659575,0.002161702127659575,Isoleucine degradation
r0633,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
r0634,-0.47430434782608694,-0.4696739130434737,-0.38356164383561636,-0.4044240619416316,FA metabolism
r0638,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
r0645,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
r0655,0.016,0.016,0.0086468085106383,0.0086468085106383,Leucine degradation
r0660,-0.47430434782608694,-0.4696739130434737,-0.38356164383561636,-0.4044240619416316,FA metabolism
r0678,0.0,0.0,0.0,0.010782967032971168,FA synthesis - cytosolic
r0681,0.0,0.0,0.0,0.010782967032971168,FA synthesis - cytosolic
r0682,0.0,0.0,0.0,-0.010782967032971168,FA synthesis - cytosolic
r0691,0.0,0.0,0.0,-0.010782967032971168,FA synthesis - cytosolic
r0692,0.0,0.0,0.0,-0.010782967032971168,FA synthesis - cytosolic
r0693,0.0,0.0,0.0,0.010782967032971168,FA synthesis - cytosolic
r0694,0.0,0.0,0.0,-0.010782967032971168,FA synthesis - cytosolic
r0695,0.0,0.0,0.0,0.010782967032971168,FA synthesis - cytosolic
r0696,0.0,0.0,0.0,-0.010782967032971167,FA synthesis - cytosolic
r0697,0.0,0.0,0.0,0.010782967032971167,FA synthesis - cytosolic
r0701,0.0,0.0,0.0,-0.010782967032971168,FA synthesis - cytosolic
r0702,0.0,0.0,0.0,0.010782967032971168,FA synthesis - cytosolic
r0712,0.0,0.0,0.0,-0.010782967032971168,FA synthesis - cytosolic
r0713,0.0,0.0,0.0,0.010782967032971168,FA synthesis - cytosolic
r0722,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.4044240619416316,FA metabolism
r0724,-0.47430434782608694,-0.4696739130434737,-0.38356164383561636,-0.4044240619416316,FA metabolism
r0726,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.4044240619416316,FA metabolism
r0728,-0.47430434782608694,-0.4696739130434737,-0.38356164383561636,-0.4044240619416316,FA metabolism
r0730,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.40442406194163105,FA metabolism
r0731,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.40442406194163105,FA metabolism
r0732,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.40442406194163105,FA metabolism
r0733,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.40442406194163105,FA metabolism
r0734,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.40442406194163105,FA metabolism
r0735,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
r0760,0.0,0.0,0.0,0.010782967032971168,FA synthesis - cytosolic
r0761,0.0,0.0,0.0,-0.010782967032971168,FA synthesis - cytosolic
r0762,0.0,0.0,0.0,0.010782967032971168,FA synthesis - cytosolic
r0763,0.0,0.0,0.0,-0.010782967032971168,FA synthesis - cytosolic
r0764,0.0,0.0,0.0,0.010782967032971168,FA synthesis - cytosolic
r0765,0.0,0.0,0.0,-0.010782967032971168,FA synthesis - cytosolic
r0766,0.0,0.0,0.0,0.010782967032971168,FA synthesis - cytosolic
r0767,0.0,0.0,0.0,-0.010782967032971168,FA synthesis - cytosolic
r0768,0.0,0.0,0.0,0.010782967032971168,FA synthesis - cytosolic
r0769,0.0,0.0,0.0,-0.010782967032971168,FA synthesis - cytosolic
r0770,0.0,0.0,0.0,0.010782967032971168,FA synthesis - cytosolic
r0771,0.0,0.0,0.0,-0.010782967032971167,FA synthesis - cytosolic
r0772,0.0,0.0,0.0,0.010782967032971167,FA synthesis - cytosolic
r0773,0.0,0.0,0.0,-0.010782967032971167,FA synthesis - cytosolic
r0791,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
r0817,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
r0829,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r0830,-0.001,-0.001,0.0,0.0,Mitochondrial transporters - characterised
r0830B_MitoCore,0.001,0.001,0.0,0.001,Mitochondrial transporters - characterised
r0838B_MitoCore,-0.3200000000000409,-0.29600000000000004,-0.22649450549450548,-0.26423489010990175,Mitochondrial transport - diffusion / artificial
r0899,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
r0913,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r0917,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r0917b_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r0940,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
r0941,0.016,0.04300000000002348,1.5108424134759562,0.6432792623383392,Mitochondrial transport - diffusion / artificial
r0942,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
r0942b_MitoCore,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
r0962B_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1078,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1088,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
r1154,0.0,0.012000000000024436,0.009187234042553193,0.009187234042549473,Threonine and Methionine degradation
r1155,0.0,0.012000000000024436,0.009187234042553193,0.009187234042549473,Threonine degradation
r1423,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
r1427,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r1434,0.001,0.001,-0.6961569838867712,0.001,Mitochondrial transporters - uncharacterised
r1435,-0.026000000000040407,-0.0019999999999999996,-0.02606593406593407,-0.06380631868133316,Mitochondrial transporters - uncharacterised
r1436,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1437,0.001,0.001,0.0,0.001,Mitochondrial transporters - uncharacterised
r1440,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1446,0.47430434782608694,0.4696739130434737,0.38956164383561637,0.41042406194163106,FA metabolism
r1447,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.4044240619416316,FA metabolism
r1448,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.4044240619416316,FA metabolism
r1450,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.40442406194163105,FA metabolism
r1451,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.4044240619416316,FA metabolism
r1455,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1512,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
r2398B_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r2402B_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r2435,0.47430434782608694,0.4696739130434737,0.38356164383561636,0.4044240619416316,Carnitine shuttle
r2525,0.0,0.0,0.0,0.0,Boundary conditions - nonessential amino acids
r2526,0.017,0.017,-0.03879656081411517,0.017,Boundary conditions - nonessential amino acids
r2532,0.01,0.01,0.01,0.01,Boundary conditions - nonessential amino acids
r2534,0.012,0.012,0.009187234042553193,0.009187234042549473,Boundary conditions - essential amino acids
